(Q33776303)

29 July 2017

Prevalence of potential proton-pump inhibitor drug interactions: a retrospective review of prescriptions in community pharmacies (English)

1 reference

29 July 2017

Saltiel E

1

1 reference

PubMed ID

10566575

29 July 2017

Fask A

series ordinal

2

1 reference

29 July 2017

1 October 1999

1 reference

29 July 2017

Clinical Therapeutics

1 reference

29 July 2017

21

1 reference

29 July 2017

10

1 reference

29 July 2017

1812-1819

1 reference

An Evaluation of the Quinolone-Theophylline Interaction Using the Food and Drug Administration Spontaneous Reporting System

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

The effects of oral doses of lansoprazole and omeprazole on gastric pH

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Interaction of propoxyphene with diazepam, alprazolam and lorazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Diazepam-cimetidine drug interaction: a clinically significant effect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Influence of lansoprazole treatment on diazepam plasma concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Effect of omeprazole and cimetidine on plasma diazepam levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Ataxia following gastric bleeding due to omeprazole-benzodiazepine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Oral phenytoin pharmacokinetics during omeprazole therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Stereoselective interaction of omeprazole with warfarin in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Pharmacokinetic interaction between lansoprazole and theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

Omeprazole drug interaction studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980059-9

7 January 2021

10.1016/S0149-2918(99)80059-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10566575